We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LTM:NYSELATAM Airlines Group S.A. Analysis

Data as of 2026-08-10 - not real-time

$56.72

Latest Price

9/10Risk

Risk Level: High

Executive Summary

LATAM Airlines Group S.A. is priced at $56.72, and its moving averages give no clean directional read — the structure is neutral. RSI sits at 58.1, which reads as neutral, and MACD momentum is bullish. Recent trading has carved out support near $49.26 and resistance around $59.18.
On valuation the read is undervalued — earnings multiple of 10.5 versus a 30.7 sector average, below the peer group. Consensus targets land 28.4% above where the shares trade now. Revenue is growing at 27.2% on a 9.9% profit margin. The 2.70% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 41.6%, a beta of 1.71 and a maximum drawdown of 33.9%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
All three time horizons resolve to buy, carrying 5/10 conviction.

Top Market Events

LTM stock surges 63.8%, fueled by robust demand, operational efficiency and award-winning customer initiatives.Yahoo Finance1monLATAM Airlines LTM : The Best Turnaround Stock to Buy in 2026The above button links to Coinbase.12dLATAM Airlines: Q2 Will Be Ugly, But The Stock Is CheapLATAM Airlines remains a Buy rating ahead of earnings but...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Trading above the 200-day average of 52.62
  • MACD momentum is positive
  • 30-day volatility of 41.6%

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • P/E of 10.5 versus sector average of 30.7
  • Trading above the 200-day average of 52.62
  • Analyst targets imply +28.4% versus the current price

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • P/E of 10.5 versus sector average of 30.7
  • Analyst targets imply +28.4% versus the current price
  • Revenue growth of +27.2%

Key Metrics & Analysis

Financial Health

Revenue Growth27.20%
Profit Margin9.85%
P/E Ratio10.5
ROE107.99%
ROA8.19%
Debt/Equity454.53
P/B Ratio9.5
Op. Cash Flow$3.7B
Free Cash Flow$1.4B
Industry P/E30.7

Technical Analysis

TrendNeutral
RSI58.1
Support$49.26
Resistance$59.18
MA 20$53.43
MA 50$53.83
MA 200$52.62
MACDBullish
VolumeStable
Fear & Greed Index93.86

Valuation

Fair Value$140.86
Target Price$72.84
Upside/Downside28.43%
GradeUndervalued
TypeBlend
Dividend Yield2.70%

Risk Assessment

Beta1.71
Volatility41.58%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.